Parkinson’s disease (PD) is a progressive neurodegenerative disease affecting millions of people worldwide. Characterized by accumulation of the protein alpha-synuclein, there is currently no cure for PD. Scientists have now developed a novel treatment effectively ameliorated disease symptoms in a mouse model of PD.